13.75 USD
-0.81 (-5.56%)
At close: Feb 11, 2026
13.75 USD
0 (0%)
After Hours: 2/11/2026, 8:00:01 PM
Taking everything into account, NRC scores 5 out of 10 in our fundamental rating. NRC was compared to 102 industry peers in the Health Care Providers & Services industry. While NRC belongs to the best of the industry regarding profitability, there are concerns on its financial health. NRC has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- NRC had positive earnings in the past year.
- NRC had a positive operating cash flow in the past year.
- NRC had positive earnings in each of the past 5 years.
- NRC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 8.60%, NRC belongs to the top of the industry, outperforming 91.18% of the companies in the same industry.
- NRC has a better Return On Equity (82.92%) than 98.04% of its industry peers.
- NRC has a Return On Invested Capital of 16.19%. This is amongst the best in the industry. NRC outperforms 93.14% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for NRC is significantly above the industry average of 9.04%.
- The 3 year average ROIC (24.89%) for NRC is well above the current ROIC(16.19%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.6% | ||
| ROE | 82.92% | ||
| ROIC | 16.19% |
ROA(3y)17.53%
ROA(5y)20.14%
ROE(3y)75.13%
ROE(5y)62.68%
ROIC(3y)24.89%
ROIC(5y)29.78%
1.3 Margins
- NRC has a Profit Margin of 8.44%. This is amongst the best in the industry. NRC outperforms 90.20% of its industry peers.
- In the last couple of years the Profit Margin of NRC has declined.
- With an excellent Operating Margin value of 16.44%, NRC belongs to the best of the industry, outperforming 95.10% of the companies in the same industry.
- NRC's Operating Margin has declined in the last couple of years.
- NRC's Gross Margin of 61.88% is amongst the best of the industry. NRC outperforms 82.35% of its industry peers.
- In the last couple of years the Gross Margin of NRC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.44% | ||
| PM (TTM) | 8.44% | ||
| GM | 61.88% |
OM growth 3Y-25.59%
OM growth 5Y-12.28%
PM growth 3Y-26.17%
PM growth 5Y-21.27%
GM growth 3Y-0.24%
GM growth 5Y-0.39%
2. Health
2.1 Basic Checks
- NRC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- Compared to 1 year ago, NRC has less shares outstanding
- The number of shares outstanding for NRC has been reduced compared to 5 years ago.
- The debt/assets ratio for NRC is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.88 indicates that NRC is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 2.88, NRC is doing good in the industry, outperforming 61.76% of the companies in the same industry.
- NRC has a debt to FCF ratio of 5.02. This is a neutral value as NRC would need 5.02 years to pay back of all of its debts.
- With a decent Debt to FCF ratio value of 5.02, NRC is doing good in the industry, outperforming 63.73% of the companies in the same industry.
- NRC has a Debt/Equity ratio of 5.36. This is a high value indicating a heavy dependency on external financing.
- The Debt to Equity ratio of NRC (5.36) is worse than 78.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.36 | ||
| Debt/FCF | 5.02 | ||
| Altman-Z | 2.88 |
ROIC/WACC1.92
WACC8.41%
2.3 Liquidity
- NRC has a Current Ratio of 0.55. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 0.55, NRC is doing worse than 85.29% of the companies in the same industry.
- NRC has a Quick Ratio of 0.55. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
- NRC's Quick ratio of 0.55 is on the low side compared to the rest of the industry. NRC is outperformed by 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.55 |
3. Growth
3.1 Past
- NRC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -50.56%.
- The Earnings Per Share has been growing slightly by 3.24% on average over the past years.
- Looking at the last year, NRC shows a decrease in Revenue. The Revenue has decreased by -3.96% in the last year.
- NRC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.42% yearly.
EPS 1Y (TTM)-50.56%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%-70.57%
Revenue 1Y (TTM)-3.96%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-4.65%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 11.00 indicates a reasonable valuation of NRC.
- Compared to the rest of the industry, the Price/Earnings ratio of NRC indicates a rather cheap valuation: NRC is cheaper than 86.27% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 28.23. NRC is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- 63.73% of the companies in the same industry are more expensive than NRC, based on the Enterprise Value to EBITDA ratio.
- 64.71% of the companies in the same industry are more expensive than NRC, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.77 | ||
| EV/EBITDA | 13.39 |
4.3 Compensation for Growth
- The excellent profitability rating of NRC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.4
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 4.16%, NRC is a good candidate for dividend investing.
- NRC's Dividend Yield is rather good when compared to the industry average which is at 0.47. NRC pays more dividend than 99.02% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.79, NRC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.16% |
5.2 History
- The dividend of NRC has a limited annual growth rate of 2.80%.
- NRC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- NRC pays out 94.64% of its income as dividend. This is not a sustainable payout ratio.
- NRC's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP94.64%
EPS Next 2YN/A
EPS Next 3YN/A
13.75
-0.81 (-5.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-03 2026-02-03/bmo
Earnings (Next)04-27 2026-04-27
Inst Owners49.6%
Inst Owner Change-2.01%
Ins Owners10.45%
Ins Owner Change2.71%
Market Cap311.30M
Revenue(TTM)137.39M
Net Income(TTM)11.60M
Analysts45
Price TargetN/A
Short Float %3.27%
Short Ratio4.7
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.16% |
Yearly Dividend0.48
Dividend Growth(5Y)2.8%
DP94.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11 | ||
| Fwd PE | N/A | ||
| P/S | 2.27 | ||
| P/FCF | 19.77 | ||
| P/OCF | 11.77 | ||
| P/B | 22.25 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.39 |
EPS(TTM)1.25
EY9.09%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.7
FCFY5.06%
OCF(TTM)1.17
OCFY8.5%
SpS6.07
BVpS0.62
TBVpS-2.3
PEG (NY)N/A
PEG (5Y)3.4
Graham Number4.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.6% | ||
| ROE | 82.92% | ||
| ROCE | 22.99% | ||
| ROIC | 16.19% | ||
| ROICexc | 16.9% | ||
| ROICexgc | 56.88% | ||
| OM | 16.44% | ||
| PM (TTM) | 8.44% | ||
| GM | 61.88% | ||
| FCFM | 11.46% |
ROA(3y)17.53%
ROA(5y)20.14%
ROE(3y)75.13%
ROE(5y)62.68%
ROIC(3y)24.89%
ROIC(5y)29.78%
ROICexc(3y)26.43%
ROICexc(5y)39.02%
ROICexgc(3y)111.05%
ROICexgc(5y)N/A
ROCE(3y)35.35%
ROCE(5y)42.3%
ROICexgc growth 3Y-50.84%
ROICexgc growth 5Y-30.78%
ROICexc growth 3Y-34.11%
ROICexc growth 5Y-17.55%
OM growth 3Y-25.59%
OM growth 5Y-12.28%
PM growth 3Y-26.17%
PM growth 5Y-21.27%
GM growth 3Y-0.24%
GM growth 5Y-0.39%
F-Score6
Asset Turnover1.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.36 | ||
| Debt/FCF | 5.02 | ||
| Debt/EBITDA | 2.48 | ||
| Cap/Depr | 140.43% | ||
| Cap/Sales | 7.79% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.54% | ||
| Profit Quality | 135.72% | ||
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.55 | ||
| Altman-Z | 2.88 |
F-Score6
WACC8.41%
ROIC/WACC1.92
Cap/Depr(3y)221.48%
Cap/Depr(5y)187.46%
Cap/Sales(3y)9.74%
Cap/Sales(5y)7.88%
Profit Quality(3y)95.08%
Profit Quality(5y)95.51%
High Growth Momentum
Growth
EPS 1Y (TTM)-50.56%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%-70.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.96%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-4.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.69%
EBIT growth 3Y-27.99%
EBIT growth 5Y-11.75%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.9%
FCF growth 3Y-15.86%
FCF growth 5Y-15.55%
OCF growth 1Y-23.61%
OCF growth 3Y-9.99%
OCF growth 5Y-8.23%
NATIONAL RESEARCH CORP / NRC FAQ
What is the ChartMill fundamental rating of NATIONAL RESEARCH CORP (NRC) stock?
ChartMill assigns a fundamental rating of 5 / 10 to NRC.
Can you provide the valuation status for NATIONAL RESEARCH CORP?
ChartMill assigns a valuation rating of 5 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Fairly Valued.
What is the profitability of NRC stock?
NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.
What are the PE and PB ratios of NATIONAL RESEARCH CORP (NRC) stock?
The Price/Earnings (PE) ratio for NATIONAL RESEARCH CORP (NRC) is 11 and the Price/Book (PB) ratio is 22.25.
Can you provide the financial health for NRC stock?
The financial health rating of NATIONAL RESEARCH CORP (NRC) is 3 / 10.